newsfilter
← Latest News
PR Newswire·

AMPIO PHARMACEUTICALS ISSUES LETTER TO STOCKHOLDERS

ENGLEWOOD, Colo., Jan. 17, 2023 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NYSE:AMPE) (the "Company") today released the following letter to stockholders from its Chairman, Kevin Buchi and Chief Executive